Caricamento...
Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions
Background: Spiromax(®) is a novel dry powder inhaler for patients with asthma or chronic obstructive pulmonary disease (COPD). The studies presented here provide further data on attributes (in vitro dosing consistency with budesonide–formoterol (DuoResp) Spiromax; flow rates through empty versions...
Salvato in:
| Pubblicato in: | J Aerosol Med Pulm Drug Deliv |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Mary Ann Liebert, Inc.
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601554/ https://ncbi.nlm.nih.gov/pubmed/26352860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2015.1216 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|